LighthouseBlood-based Biomarkers in CancerLiquid biopsy for cancer is non-invasive and easily repeated, permitting molecular profiling and many other purposes with strong accuracy.
LighthouseBlood-based Biomarkers in Alzheimer’s DiseaseBlood-based biomarkers (BBMs) hold promise for a fast, convenient, and simple means to accurately diagnose Alzheimer's Disease.
LighthouseHow Does Awareness of Biomarkers Compare to Prevalence?We compared awareness in oncologists of selected biomarkers to the prevalence of actionable oncogenic mutations across cancers.
LighthouseRAS Biomarker Trending and Awareness in OncologistsWe examined RAS/KRAS trending and awareness for oncologists; results track strongly with the history of scientific KRAS advancements.
LighthouseNTRK Trending and Awareness in Community OncologistsWe analyzed trending and awareness patterns of NTRK and NTRK-targeting compounds in academic and community oncologists.
LighthouseWhat is an Awareness Algorithm?Awareness of new and emerging cancer biomarkers and compounds is vital so HCPs will test for and treat molecular oncogenic drivers.